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modulation of glial activation and
dopaminergic damage in a rat
model of Parkinson’s disease using
[11C]PBR28 and [18F]FDOPA PET
Caroline C Real1,2,3, Janine Doorduin2, Paula Kopschina Feltes2,
David Va´llez Garcı´a2, Daniele de Paula Faria3, Luiz R Britto1
and Erik FJ de Vries2
Abstract
Evidence suggests that exercise can modulate neuroinflammation and neuronal damage. We evaluated if such effects of
exercise can be detected with positron emission tomography (PET) in a rat model of Parkinson’s disease (PD). Rats were
unilaterally injected in the striatum with 6-hydroxydopamine (PD rats) or saline (controls) and either remained sedentary
(SED) or were forced to exercise three times per week for 40min (EX). Motor and cognitive functions were evaluated
by the open field, novel object recognition, and cylinder tests. At baseline, day 10 and 30, glial activation and dopamine
synthesis were assessed by [11C]PBR28 and [18F]FDOPA PET, respectively. PET data were confirmed by immunohisto-
chemical analysis of microglial (Iba-1) / astrocyte (GFAP) activation and tyrosine hydroxylase (TH). [11C]PBR28 PET
showed increased glial activation in striatum and hippocampus of PD rats at day 10, which had resolved at day 30.
Exercise completely suppressed glial activation. Imaging results correlated well with post-mortem Iba-1 staining, but not
with GFAP staining. [18F]FDOPA PET, TH staining and behavioral tests indicate that 6-OHDA caused damage to dopa-
minergic neurons, which was partially prevented by exercise. These results show that exercise can modulate toxin-
induced glial activation and neuronal damage, which can be monitored noninvasively by PET.
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Introduction
Parkinson’s disease (PD) is the second most common
neurodegenerative disease among elderly and aﬀects
approximately 30 million people worldwide.1 PD
patients account for a large portion of healthcare
expenditures and represents a huge social and economic
burden.2,3 Thus, adequate prevention and treatment
strategies for PD are required.
One possible strategy to delay the onset and progres-
sion of PD is regular exercise since exercise was found
to be inversely related to the incidence of neurodegen-
erative diseases.4,5 Exercise is a cheap and widely prac-
ticed activity that stimulates the molecular and cellular
cascades that support and maintain brain plasticity.6,7
Intermittent exercise can lead to improvement of the
dopaminergic system and recovery of motor behavior
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in an animal model of PD.8 Exercise induces an
increase in the neurotrophic factors, that play an
important role in central nervous system protection
and recovery.5,9,10 An increase in neurotrophic factors
in the nigrostriatal system can improve mitochondrial
function and protect neurons from the detrimental
eﬀects of a neurotoxin.11 Besides neurotrophic factors,
vascular endothelial growth factor and insulin growth
factor 1 can reduce the levels of pro-apoptotic proteins
and thus seem to indirectly participate in neuroprotec-
tion.5,7 This suggests that exercise may reduce the risk
of developing neurodegenerative disorders and delay
disease progression.5 To enable monitoring of the pro-
tective eﬀects of exercise on brain functions in longitu-
dinal study designs and to facilitate the translation of
preclinical results to humans, noninvasive functional
imaging tools would be desirable.
Positron emission tomography (PET) is an attractive
tool for acquiring functional information on patho-
logical processes in the brain. 6-[18F]Fluoro-L-3,4-dihy-
droxyphenylalanine ([18F]FDOPA) has been used as a
PET tracer to monitor aromatic L-amino acid decarb-
oxylase (AADC) activity in dopaminergic neurons.
Since AADC is responsible for the conversion of
DOPA into dopamine, [18F]FDOPA PET has been
used as surrogate marker for the dopamine synthesis
rate and presynaptic dopaminergic neuronal integrity.
A decline in tracer uptake in striatum correlates
with the severity of dopaminergic dysfunction.12
[18F]FDOPA PET enables the detection of presynaptic
dopaminergic deﬁcits in PD patients with excellent sen-
sitivity and speciﬁcity, even in the early phases of the
disease.13 Thus, [18F]FDOPA PET could be a useful
tool to evaluate the eﬃcacy of novel treatment strate-
gies for PD, like exercise.14,15
Neuroinﬂammation can be detected in PD patients
before a decrease in dopaminergic function can be
observed with [18F]FDOPA PET.16 Glial activation is
an important hallmark of neuroinﬂammation. Upon
activation, microglia and astrocytes increase the expres-
sion of the 18kD-translocator protein (TSPO) in the
outer mitochondrial membrane.17–20 Overexpression
of TSPO can be detected by PET with a suitable
tracer. The TSPO ligand [11C]-(R)-PK11195 has been
most frequently used to evaluate glial activation.
However, this PET tracer has some limitations21,22
and therefore second generation of TSPO PET tracers
has been developed. [11C]PBR28 is a second generation
TSPO tracer that has been applied successfully in both
preclinical and clinical studies.17,21–23
In the present study, we aimed to investigate the
beneﬁcial eﬀects of exercise on glial activation and
dopaminergic system degeneration in a PD model,
using [11C]PBR28 and [18F]FDOPA PET, respectively.
Postmortem immunohistochemical analysis was
performed to conﬁrm PET imaging results. As an
animal model for PD, rats were treated by unilateral
striatal injection of 6-hydroxydopamine (6-OHDA).
Motor and cognitive functions were assessed in behav-
ioral tests and correlated to imaging data.
Material and methods
Experimental animals
Animal experiments were carried out according to the
Dutch Regulations for Animal Welfare. All procedures
were approved by the Institutional Animal Care and
Use Committee of the University of Groningen (DEC
6689F) and reported in compliance with ARRIVE
guidelines. Outbred male Hannover-Wistar rats
(three months, n¼ 44) were purchased from Janvier
labs (France) and group-housed in thermo-regulated
(21 2C) and humidity-controlled rooms, under an
inverted 12–12-h light-dark cycle (lights on at 12 PM).
Food and water were available ad libitum. The rats were
allowed to acclimatize for at least seven days. Animals
were fed with standard laboratory chow (RM1. Special
diets services, UK). Animals were randomly divided
into 4 groups of 11 animals each: (1) sedentary control
animals (SED), which were injected with vehicle into
the right striatum; (2) exercised control animals (EX),
which were injected with vehicle into the right striatum
and were forced to exercise from day 2 after the surgery
until the end of the experiment; (3) sedentary PD ani-
mals (SEDþPD), which were injected with 6-OHDA
into the right striatum; and (4) exercised PD animals
(EXþPD), which were injected with 6-OHDA into
right striatum and were forced to exercise from day 2
after the surgery until the end of the experiment. For
each group, eight animals per group were assigned to
the PET procedures and three animals were terminated
on day 10 for immunohistochemistry. Sample size cal-
culation was performed with G*Power 3.1.9.2 software
(Universita¨t Du¨sseldorf, Germany) based on published
data for [18F]FDOPA PET15 and tyrosine hydroxylase
(TH) expression24 in PD rats. We expected exercise to
have a smaller eﬀect than 6-OHDA injection. Assuming
an eﬀect size of 1.7 (power 80%; alpha 0.05), the sample
size was estimated to be 8. Sample size calculation for
Iba-1 and GFAP immunohistochemistry at day 10 was
based on published data.24 Assuming an eﬀect size of
3.36 (power 80%; alpha 0.05), the sample size was esti-
mated to be 3. Figure 1 summarizes the experimental
design. Two animals died during surgery (both SED
group) and one died during the PET scan at day 10
(EX group). Data from some animals were lost due to
methodological issues. The numbers of animals
included in the analysis for each experiment are indi-
cated in the tables in the Supplementary data.
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Investigators were not blinded for group allocation,
since PET imaging analysis was fully automated and
thus operator-independent.
Surgical procedure
The animals were anesthetized with isoﬂurane mixed
with oxygen (5% induction, 2% maintenance,
0.8 L/min) and placed in a stereotaxic apparatus
(Kopf instruments, Germany). After craniotomy, two
0.5 mL aliquots of 3 mg 6-OHDA hydrochloride (H4381,
Sigma) and 0.3% ascorbic acid in saline (PD animals)
or 0.3% ascorbic acid in saline (control animals) were
injected with a microinjection pump (CMA 100, CMA
Microdialysis AB, Sweden) over a period of 5min each.
The solutions were injected into the right striatum at
the following coordinates: (1) AP: þ1.12, L: 2.6, V:
5mm; (2) AP: þ0.2, L: 3.0, V: 4.5mm relative to
Bregma and ventral to the dura mater.25 After infusion,
the syringe needle (Hamilton 51315-02) was left in the
infused region for 3min to avoid reﬂux of the solution.
The incision was sutured and the animals were kept
isolated in cages for two days. To reduce discomfort,
pain medication (ﬂunixin-meglumin – 1mg/kg, s.c.) was
given before surgery and at 24 h after surgery. If the
rats still showed signs of discomfort after 48 h, an
extra dose of analgesic was given.
Exercise
Rats were forced to exercise in a motorized running
wheel for three days per week, starting two days after
surgery. All animals, including animals from the seden-
tary groups, were adapted to the motorized running
wheel (TSE systems, 303400 series, 252mm diameter)
between baseline measurements and surgery by
forcing them to run for 15min on two consecutive
days (6.7m/min). Exercised animals were subjected to
a moderate exercise protocol at a speed of 10m/min for
40min (13 revolutions/min, approximately 400m/
day).8,26 SED and SEDþPD animals were placed in
cages near the running wheel to become familiarized
with the novel surrounding.
Open field test
Animals were individually submitted to the open ﬁeld
arena (100 100 40 cm) for 10min before the baseline
PET scan (6 days before surgery) and 28 days after
surgery. The parameters analyzed included total dis-
tance moved and speed.27,28 The open ﬁeld arena was
cleaned with 70% ethanol before each behavioral test
to eliminate possible bias due to odors left by previous
rats.29 The behavioral tests were video-recorded and
analyzed using the Ethovision XT8.5 software
(Noldus Information Technology, The Netherlands).
Novel object recognition
NOR is a test that analyzes both short-term and long-
term working memory, depending on the interval
between tests.30 The experiment was carried out at
baseline and 28 days after surgery. All objects used
for the test had similar textures, colors, and sizes, but
distinctive shapes. The rats were placed in a square
black arena (50 50 40 cm) containing two identical
objects (A1þA2) for the habituation and training
phase, as previously described,31 but with some
Figure 1. Experimental design. Sedentary controls (SED); Exercised controls (EX); Sedentary PD rats (SEDþ PD); and exercised PD
rats (EXþ PD). Open field test (OFT); Novel object recognition (NOR); short-term memory (SM); long-term memory (LM).
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modiﬁcations.27 After 5min, the rats were removed
from the arena and placed into their home cage. After
1 h (short-term memory, SM)32 and 24 h (long-term
memory, LM), the rats were placed in the arena again
for 5min, with one objects replaced by a novel object
(SM: BþA2, LM: CþA2). The 28-day test was carried
out with new objects (D1þD2, EþD2, FþD2). The
behavioral tests were video-recorded for further ana-
lysis. Exploration of an object is deﬁned as the time
the animal spends with its head oriented towards the
object, within two centimeters from the object
(sniﬃng). The discrimination index was calculated by:
[(time exploring the new object)/(total time exploring
the two objects)] 100%.27,33
Cylinder test
The cylinder test is a test for unilateral deﬁcits in vol-
untary forelimb use.27,34 The cylinder test was per-
formed at baseline, day 9 and 29 after surgery. Rats
were placed in a transparent cylinder (diameter:
20 cm, height: 30 cm) for 5min, with a mirror located
behind the cylinder to allow a 360 vision.35 The
number of forepaw contacts to the cylinder wall was
counted.35,36 The cylinder test was scored as the contra-
lateral bias: [(the number of contralateral limb contact)/
(number of total limbs contacts)] 100%.27,35 Healthy
rats should score on average 50% in this test.37
Immunohistochemistry
On day 10 and 30 after surgery, animals were anesthe-
tized with ketamine (60mg/kg i.p.) and medetomidine
(0.4mg/kg i.p.), and perfused through the left ventricle
with 4% paraformaldehyde in phosphate-buﬀered
saline (PBS, pH 7.4). Anti-TH (mouse monoclonal,
Millipore MAB5280), anti-ionized calcium-binding
adapter molecule 1 (Iba-1, microglia marker) (rabbit
polyclonal, Wako laboratory Chemicals 019-19741),
and anti-glial ﬁbrillary acidic protein (GFAP, astrocyte
marker) (mouse monoclonal, Sigma-Aldrich G3893)
antibodies were used. The secondary antibody was a
biotinylated donkey anti-mouse IgG for TH and
GFAP (715-065-151, Jackson Laboratories), and a bio-
tinylated goat anti-rabbit IgG for Iba1 (111-065-003,
Jackson Laboratories). The protocol was the same as
used previously.8,26 Coronal brain sections (30 mm)
were incubated overnight at 22C with a primary anti-
body solution containing 5% normal donkey serum
(for TH and GFAP), or normal goat serum (for Iba-
1) in 0.3% Triton X-100 in PBS diluted 1:1000. Sections
were subsequently incubated with a 1:200 diluted sec-
ondary antibody solution for 2 h. The sections were
processed with the ABC Elite kit (Vector Labs, USA)
for 2 h and the labeling was developed with 0.05%
diaminobenzidine tetrahydrochloride and 0.03%
hydrogen peroxide in PBS.
Immunohistochemistry analysis
Digital images of ﬁve stained sections (150mm between
sections) of striatum, SNc and hippocampus were
acquired from each rat using a microscope and digital
camera. A stereotaxic atlas was used as an anatomical
reference.25 The integrated density of Iba-1 and GFAP
staining was measured with the Imaging J threshold
plugin (Image J, NIH/USA). For TH staining in SNc,
the number of positive cells was also counted with the
cell counter plugin and represented as positive cells per
mm2. For analysis of TH staining in striatum, three
areas of 0.0044 mm2 for each slice were selected to
avoid regions of ﬁber bundles. For other regions and
antibodies, random areas of 0.18 mm2 were selected. To
avoid inclusion of the mechanical damage by the injec-
tion in the analysis, only slices at a distance of at least
50 mm from the injection site were analyzed. Optical
density for right and left hemispheres was assessed sep-
arately and as experimental-to-control hemisphere
ratios.8
PET imaging
PET scans were acquired at baseline and at day 10 and
30 after surgery using a small-animal PET camera
(Focus 220, Siemens Medical Solutions, USA).
[11C]PBR28 PET was performed in the morning, and
[18F]FDOPA PET in the afternoon, with at least 3-h
interval. Two rats from diﬀerent experimental groups
were scanned simultaneously in each scanning session.
Rats were anesthetized with isoﬂurane mixed with
oxygen (5% induction, 2% maintenance, 0.8 L/min).
Thirty minutes before [18F]FDOPA injection, the per-
ipherally acting AADC inhibitor, benserazide hydro-
chloride (20mg/kg, 10mg/mL in PBS, AvaChem
Scientiﬁc, New Jersey, USA), and the catechol-
O-methyl transferase inhibitor, Entacapone (20mg/kg,
50mg/mL in DMSO, AvaChem Scientiﬁc, New Jersey,
USA) were administered i.p. to reduce tracer metabol-
ism.14,15 Rats were positioned in the camera in a trans-
axial position with their heads in the center of the ﬁeld
of view. A 10-min transmission scan with a 57Co point
source was performed to correct for attenuation, scatter
and random coincidences during image reconstruction.
The animals were injected with 48 22 MBq
[11C]PBR28 or 25 3 MBq [18F]FDOPA via the
penile vein. The injected amount of [11C]PBR28
(0.86 0.70 nmol, p¼ 0.98) and [18F]FDOPA (304
147 nmol, p¼ 0.99) was not signiﬁcantly diﬀerent
between groups and time points. After a tracer distri-
bution time of 40min for [11C]PBR28 or 60min for
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[18F]FDOPA, a 30-min static emission scan was
acquired. The body temperature of the rats was main-
tained with heating pads, eye lubricant was applied
onto the eyes to prevent dehydration, and heart rate
and blood oxygen levels were monitored with a
BioVet system (M2M Imaging, USA). After the
scans, the rats were either allowed to recover in their
home cages or terminated for immunohistochemistry.
PET image reconstruction and analysis
Emission sinograms were iteratively reconstructed into
a single frame of 30min (OSEM 2D; 4 iterations and 16
subsets), after being normalized and corrected for
attenuation, scatter, and decay of radioactivity. PET
image processing was performed with PMOD 3.7 soft-
ware (PMOD Technologies Ltd, Switzerland). Scans
were automatically registered to tracer-speciﬁc PET
templates38 constructed from the baseline scans
acquired in this study. Volumes of interest (VOI) were
constructed based on previously deﬁned templates.38
Separate VOIs for left and right striatum, midbrain
and hippocampus were used for [11C]PBR28 PET ana-
lysis. VOIs for striatum and cerebellum were con-
structed for [18F]FDOPA PET analysis. The brain
radioactivity concentration was calculated in each
VOI and expressed as standardized uptake value
(SUV): [tissue activity concentration (MBq/g) body
weight (g)]/[injected dose (MBq)]. A tissue density of
1 g/ml was assumed. The imaging data were expressed
as tracer uptake in the experimental and control hemi-
sphere separately and as the ratio between hemispheres.
[18F]FDOPA uptake was normalized to the cerebellum
uptake (striatal uptake divided by the uptake in cere-
bellum)39,40 to correct for metabolite accumulation
inside the brain.39 Cerebellum was considered a refer-
ence region devoid of dopamine synthesis. [11C]PBR28
data were not normalized to a reference region, because
there is no brain region devoid of TSPO receptors.
Statistical analysis
Data are presented as mean standard error of the
mean (SEM). Statistical analyses of baseline data
from behavioral tests and PET imaging were performed
using one-way ANOVA. After surgery, data were ana-
lyzed using two-way ANOVA, followed by a Tukey
posthoc correction for multiple comparisons whenever
appropriate. ‘Exercise’ and ‘surgery’ were used as the
variables between groups. Statistical analysis of
changes in body weight was performed using the gen-
eralized estimating equations (GEE) model with inde-
pendent correlation matrix to account for repeated
measurements and missing data in the longitudinal
design.41 The variables ‘time point’, ‘group’ and the
interaction ‘time point’ ’group’ were included in a
factorial design. Diﬀerences were considered statistic-
ally signiﬁcant when p< 0.05. The correlation between
TH staining and [18F]FDOPA uptake was analyzed
with a linear regression method. Within-group
comparison between baseline and post-surgery data
was performed by a paired Student’s t-test. All data




No signiﬁcant diﬀerences in body weight between
groups [F(3,40)¼ 0.31; p¼ 0.82] were observed at base-
line (Figure 2(a), Supplementary Table 1). 6-OHDA
injection signiﬁcantly decreased body weight in the
ﬁrst week after surgery (SED vs. SEDþPD
p< 0.0001; EX vs. EXþPD p< 0.01). All groups sig-
niﬁcantly gained body weight from the second week
after surgery onward. Body weight increased about
22 g/week in sedentary animals (p< 0.0001) and only
about 14 g/week in exercised animals (p< 0.0001).
Consequently, EXþPD animals were signiﬁcantly
lighter at the end of the experiment than SEDþPD
animals (ca. 8%, p< 0.05).
Open field
At baseline, no signiﬁcant diﬀerences in distance tra-
veled and average speed between groups were observed
[(Distance: F(3,31)¼ 0.22, p¼ 0.88); Speed: F(3,31)¼
0.75, p¼ 0.53)]. At day 28, animals from all groups
showed a decrease in the distance traveled and average
speed, when compared to baseline (ca. 50%, p< 0.001).
However, no signiﬁcant diﬀerences between experimen-
tal groups were observed at day 28 [(Distance:
F(1,25)¼ 0.23, p¼ 0.63); Speed: F(1,25)¼ 0.46, p¼
0.50)] (Supplementary Table 2).
Novel object recognition
When exposed to similar objects, no signiﬁcant
diﬀerences in the time spent exploring each object
were observed, neither at baseline [F(3,32)¼ 0.83,
p¼ 0.49] nor at day 28 [F(3,25)¼ 2.26, p¼ 0.11]
(Supplementary data – Table 3). No between-group dif-
ferences in short-term memory (F(3,32)¼ 0.51,
p¼ 0.68) and long-term memory (F(3,32)¼ 2.63,
p¼ 0.07) were found at the baseline. Within-group
comparison of short-term memory showed that the
memory index of SEDþPD animals was signiﬁcantly
reduced between baseline and day 28 (23%, p< 0.01),
whereas the long-term index of memory retention was
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also decreased (27%, p< 0.0001). Other groups did
not show any signiﬁcant diﬀerences in short-term or
long-term memory between baseline and day 28. As a
result, between-group comparison at day 28 after sur-
gery (Figure 2(b)) showed a signiﬁcantly lower (ca.
28%, F(1,25)¼ 7.02, p¼ 0.01) short-term index of
memory retention for SEDþPD animals than for
other groups (SED p< 0.05; EXþPD p< 0.01).
Long-term memory of the SEDþPD group also
showed a signiﬁcantly lower eﬀect for lesion
[F(1,25)¼ 4.61, p¼ 0.04] and exercise [F(1,25)¼ 10.58,
p¼ 0.003], when compared to other groups (ca. 25%,
SED p< 0.05; EX and EXþPD p< 0.01).
Cylinder test
At baseline, asymmetric forelimb use was not signiﬁ-
cantly diﬀerent between groups [F(3,40)¼ 2.40;
p¼ 0.08]. At day 9, the SEDþPD group showed sig-
niﬁcantly lower contralateral forelimb use than other
groups (SED 35%, EX 30%, EXþPD 35%,
p< 0.0001) [F(1,38)¼ 42.24; p< 0.0001]. At day 29,
no signiﬁcant diﬀerences between groups were observed
anymore [F(1,25)¼ 0.01; p¼ 0.92] (Figure 2(c),
Supplementary data – Table 4).
[11C]PBR28 PET
[11C]PBR28 uptake was analyzed for total midbrain,
since the SNc could not be reliably delineated in the
PET images due to the limited spatial resolution of
the PET camera (1.4mm). Tracer uptake in the aﬀected
midbrain did not signiﬁcantly diﬀer between groups at
any time point (baseline [F(3,52)¼ 0.42; p¼ 0.74]; day
10 [F(3,48)¼ 0.499, p¼ 0.068]; day 30 [F(3,50)¼ 0.75,
p¼ 0.52]) and neither did the ratio between the aﬀected
and control midbrain (baseline [F(3,26)¼ 0.88;
p¼ 0.47]; day 10 [F(1,24)¼ 1.44, p¼ 0.24]; day 30
[F(1,25)¼ 0.11, p¼ 0.74]) (Supplementary data –
Table 5). [11C]PBR28 uptake in the aﬀected striatum
of the SEDþPD group was signiﬁcantly increased at
day 10 (F(3,48)¼ 4.68, p¼ 0.006), but not at baseline
(F(3,52)¼ 2.049; p¼ 0.12) or day 30 (F(3,50)¼ 0.55,
p¼ 0.65). Consequently, the uptake ratio between
hemispheres in the SEDþPD group at day 10 was sig-
niﬁcantly higher when compared to baseline (60%,
p< 0.0001) and to the striatal uptake ratio in other
groups at day 10 (ca. 49%, p< 0.01F(1,24)¼ 7.55,
p¼ 0.01). At day 30, no signiﬁcant diﬀerences in striatal
uptake between hemispheres or between groups
were observed anymore [F(1,25)¼ 2.46; p¼ 0.13]
(Figure 3). In hippocampus, there was no signiﬁcant
diﬀerence in tracer uptake between hemispheres or
between groups at baseline [F(3,26)¼ 0.62; p¼ 0.61].
At day 10, SEDþPD animals showed signiﬁcant
eﬀects for 6-OHDA injection [F(1,26)¼ 5.50; p¼ 0.03]
and for exercise [F(1,26)¼ 5.74; p¼ 0.03]. In particular,
[11C]PBR28 uptake in the aﬀected hippocampus of
SEDþPD rats was signiﬁcantly increased when
compared to baseline and to other groups at day 10
(ca. 30%, p< 0.001) [F(1,26)¼ 7.55, p¼ 0.01].
Figure 2. (a) Body weight of the animals throughout the
experimental protocol. SEDþ PD vs. EXþ PD (*p< 0.05). (b)
Results of the novel object recognition test for short-term (left)
and long-term (right) memory 28/29 days after surgery. Results
are expressed as index of memory retention. (c) Cylinder test
data, showing the percentage of the contralateral forelimb use at
baseline, 9 days and 29 days after the surgery. Sedentary controls
(SED); Exercised controls (EX); Sedentary PD rats (SEDþ PD);
and exercised PD rats (EXþ PD). *p< 0.05; **p< 0.01;
***p< 0.001; ****p< 0.0001.
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No signiﬁcant diﬀerences in hippocampal [11C]PBR28
uptake were observed anymore at day 30
[F(1,25)¼ 2.16; p¼ 0.15] (Figure 4) (Supplementary
data – Table 5).
Ionized calcium-binding adapter molecule 1
Iba-1 staining was performed on SNc, striatum, and
hippocampus sections (Figure 5(a) to (c)). Injection of
6-OHDA caused a signiﬁcant increase in Iba-1 staining
in all analyzed regions at day 10 after surgery
(SEDþPD vs. SED: SNc þ 120%; p< 0.001; striatum
þ 94%, p< 0.001; hippocampusþ 164%, p< 0.01).
Exercise completely suppressed the 6-OHDA-induced
activation of microglia at day 10, as Iba-1 staining in
all investigated brain regions of the EXþPD group
was reduced to the level of exercised controls
(EXþPD vs. SEDþPD: SNc  53%, p< 0.01; stri-
atum  79%, p< 0.001; hippocampus  178%,
p< 0.01) (SNc [F(1,8)¼ 33.35, p¼ 0.0004]; striatum
[F(1,8)¼ 29.37, p¼ 0.0006]; hippocampus
[F(1,8)¼ 17.71, p¼ 0.003]). At day 30, microglial acti-
vation was still increased in SNc (EXþPD vs.
SEDþPD p¼ 0.71; SEDþPD vs. SED:þ56%,
p< 0.0001; EXþPD vs. EX:þ 68%, p< 0.0001)
[F(1,25)¼ 59.17, p< 0.0001]. In contrast, Iba-1 staining
in striatum and hippocampus of EXþPD rats was
completely normalized to the level of sedentary controls
(striatum [F(1,25)¼ 3.66, p¼ 0.07]; hippocampus
[F(1,25)¼ 2.29, p¼ 0.14]). Exercise caused a small but
signiﬁcant reduction in Iba-1 staining in striatum of 6-
OHDA-treated animals at day 30 (EXþPD vs.
SEDþPD: 17%, p< 0.05), despite Iba-1 staining in
SEDþPD animals not being signiﬁcantly diﬀerent
Figure 3. Results of [11C]PBR28 PETat baseline, 10 days and 30 days after surgery. (a) Tracer uptake in the experimental (right) and
control (left) striatum, expressed as Standard Uptake Value (SUV). (b) Tracer uptake ratio between experimental and control striatum.
(c) Examples of transaxial [11C]PBR28 PET images of the striatal region acquired at day 10 after surgery. The hemisphere of sedentary
animals in which 6-OHDA was injected shows increased [11C]PBR28 uptake (red arrow). Note that exercise reversed this effect,
resulting in a normalization of [11C]PBR28 uptake in the EXþ PD group (green arrow). Sedentary controls (SED); Exercised controls
(EX); Sedentary PD rats (SEDþ PD); and exercised PD rats (EXþ PD). Standard uptake value (SUV). Statistical differences between
groups for the same brain hemisphere and between hemispheres for same group are presented as *p< 0.05; **p< 0.01; ***p< 0.001;
statistical differences between baseline and day 10 and 30 are indicated by #p< 0.05; ##p< 0.01; ####p< 0.0001.
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from sedentary controls (Supplementary data – Figure
S1, Table 5).
Glial fibrillary acidic protein
6-OHDA injection or exercise did not have any signiﬁ-
cant eﬀect on GFAP optical density in the SNc or
hippocampus at day 10 (SNc: [F(1,8)¼ 3.55, p¼ 0.10];
hippocampus: [F(1,8)¼ 0.23, p¼ 0.65]) or 30 after sur-
gery (SNc: [F(1,25)¼ 0.31, p¼ 0.58]; hippocampus:
[F(1,25)¼ 0.42, p¼ 0.52]). On the other hand, 6-
OHDA injection caused a signiﬁcant increase in astro-
cyte staining in striatum at day 10 after surgery
(SEDþPD vs. SED þ 164%, p< 0.01). Exercise
could not suppress this eﬀect (EX-PD vs. SED-PD
p¼ 0.92; EXþPD vs. SED þ 141%, p< 0.05)
[F(1,8)¼ 25.90, p¼ 0.0009]. At day 30, the 6-OHDA
eﬀect on astrocyte activation in striatum had not com-
pletely disappeared. Instead, GFAP staining in stri-
atum was signiﬁcantly reduced in exercised PD rats
(EX-PD vs. SED-PD 30%, p< 0.05) with signiﬁcant
eﬀects for 6-OHDA [F(1,25)¼ 7.44, p¼ 0.01] and for
exercise [F(1,25)¼ 9.23, p¼ 0.005] (Figure 5(d) to (f),
Supplementary data – Figure S2, Table 5).
[18F]FDOPA PET
[18F]FDOPA uptake in striatum did not show any sig-
niﬁcant diﬀerences between hemispheres or between
groups at baseline [F(3,22)¼ 0.34; p¼ 0.79]. Fours ani-
mals (one from each group) did not undergo a baseline
[18F]FDOPA scan, due to tracer production failures.
Figure 4. Results of [11C]PBR28 PETat baseline, 10 days and 30 days after surgery. (a) Tracer uptake in the experimental (right) and
control (left) hippocampus, expressed as Standard Uptake Value (SUV). (b) Tracer uptake ratio between experimental and control
hippocampus. (c) Examples of transaxial [11C]PBR28 PET images of the hippocampus region acquired at day 10 after surgery. The
hemisphere of sedentary animals in which 6-OHDA was injected shows increased [11C]PBR28 uptake (red arrow). Note that exercise
reversed this effect, resulting in a normalization of [11C]PBR28 uptake in the EXþ PD group (green arrow). Sedentary controls (SED);
Exercised controls (EX); Sedentary PD rats (SEDþ PD); and exercised PD rats (EXþ PD). Standard Uptake Value (SUV). Statistical
differences between groups for the same brain hemisphere and between hemispheres for same group are presented as *p< 0.05;
**p< 0.01; ***p< 0.001; ***p< 0.0001. Statistical differences between baseline and day 10 and 30 are indicated by ###p< 0.001.
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The within-group comparison showed that 6-OHDA
injection caused a signiﬁcant reduction in
[18F]FDOPA uptake in the aﬀected striatum of seden-
tary PD rats between baseline and day 30 (18%,
p< 0.01). Exercised PD animals showed a substantially
smaller reduction in [18F]FDOPA uptake between base-
line and day 30 (6%, p< 0.05), suggesting exercise
could partially protect the dopaminergic system.
Between-group comparison at day 30, conﬁrmed that
sedentary PD rats had signiﬁcantly lower [18F]FDOPA
uptake in the aﬀected striatum than sedentary controls
(SEDþPD vs. SED  17%, p< 0.001). In contrast,
[18F]FDOPA uptake in exercised PD rats at day 30
was not signiﬁcantly diﬀerent from controls (EXþPD
vs. EX p¼ 0.36; EXþPD vs. SED p¼ 0.30) and
signiﬁcantly higher than in sedentary PD rats
(EXþPD vs. SED þPDþ 12%, p< 0.05)
[F(1,25)¼ 4.43; p¼ 0.04] (Figure 6) (Supplementary
data – Table 6).
TH
Injection of 6-OHDA caused a signiﬁcant decrease
in the percentage of TH-positive cells in the SNc
(Figure 7(a)) of both sedentary (SED-PD vs. SED
 42%, p< 0.001) and exercised PD rats (EXþPD
vs. EX  38%, p< 0.01) at day 10 after surgery
[F(1,8)¼ 62.38, p< 0.0001]. At day 30, the percentage
of TH-positive cells in SNc was still signiﬁcantly
reduced in sedentary PD rats (SEDþPD vs. SED
Figure 5. Iba-1 immunostaining of activated microglia 10 days and 30 days after the surgery in the experimental (right) and control
(left) substantia nigra (a), striatum (b) and hippocampus (c). Note the peak of microglial activation in the SEDþ PD animals at 10 days
after the surgery for all the structures analyzed. At day 30, both groups of PD rats still revealed an increase in the microglial activation
in the substantia nigra. Statistical differences between groups for the same brain hemisphere and between hemispheres for same group
are presented as *p< 0.05; **p< 0.01; ***p< 0.001; ****p< 0.0001.
GFAP immunostaining of astrocytes 10 days and 30 days after the surgery in the experimental (right) and control (left) substantia nigra
(d), in the striatum (e) and in the hippocampus (f). Note the peak of astrocyte activation in the striatum of PD rats at 10 days after the
surgery, which normalized to control levels at 30 days in the exercised PD rats. Statistical differences between groups for the same
brain hemisphere and between hemispheres for same group are presented as *p< 0.05; **p< 0.01; ***p< 0.001; ****p< 0.0001.
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 46%, p< 0.001). In exercised PD rats, however, the
percentage of TH-positive cells was not signiﬁcantly
diﬀerent from exercised controls (EXþPD vs. EX
p¼ 0.06), and signiﬁcantly higher than in sedentary
PD rats (EXþPD vs. SEDþPD 41%, p¼ 0.05)
[F(1,25)¼ 31.31, p< 0.0001]. TH staining in striatum
at day 10 (Figure 7(b)) was also signiﬁcantly lower in
6-OHDA-injected animals than in saline controls
(SEDþPD vs. SED  51%, p< 0.01; EXþPD vs.
EX  31%, p< 0.05). Although the reduction in TH
staining was substantially smaller in exercised than in
sedentary PD rats, this diﬀerence was not statistically
signiﬁcant (EXþPD vs. SEDþPD 47%, p¼ 0.09),
indicating no interaction between factors but signiﬁ-
cance for 6-OHDA [F(1,8)¼ 52.47, p< 0.0001] and
exercise [F(1,8)¼ 5.84, p¼ 0.04]. Thirty days after sur-
gery, the sedentary PD group still showed signiﬁcantly
decreased TH staining in striatum (SEDþPD vs. SED
 20%, p< 0.01). However, TH staining in striatum
had completely normalized to control levels in exercised
PD rats (EXþPD vs. EX p¼ 0.50), although the dif-
ference from sedentary PD rats was not signiﬁcant yet
(EXþPD vs. SEDþPD 14%, p¼ 0.23)
[F(1,25)¼ 12.53, p¼ 0.002]. Interestingly, the TH
Figure 6. Results of [18F] FDOPA PETat baseline and 30 days after surgery. (a) Tracer uptake in the experimental (right) and control
(left) striatum is normalized to the uptake in cerebellum and expressed as Standard Uptake Value (SUV) (b) Tracer uptake ratio
between right and left striatum. (c) Examples of [18F]FDOPA PET images of transaxial brain sections containing the striatum, acquired
at day 30 after surgery. [18F]FDOPA uptake is reduced in the striatum injected with 6-OHDA in sedentary animals (red arrow). Note
that exercise partly reversed this effect in EXþ PD animals (green arrow). Sedentary controls (SED); Exercised controls (EX);
Sedentary PD rats (SEDþ PD); and exercised PD rats (EXþ PD). Statistical differences between groups for the same brain hemi-
sphere and between hemispheres for same group are presented as *p< 0.05; **p< 0.01; ***p< 0.001; ****p< 0.0001. Statistical
differences in tracer uptake between baseline and day 30 are indicated as #p< 0.05; ## p< 0.01; ###p< 0.001.
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Figure 7. (a) The number of TH-positive cells per mm2 for right and left substantia nigra 10 days and 30 days after surgery; (b) TH
optical density for in the affected (right) and contralateral (left) striatum 10 days and 30 days after surgery; (c) Correlation between
[18F]FDOPA uptake (SUV) ratio and TH staining ratio for striatum at 30 days after surgery. Sedentary controls (SED); Exercised
controls (EX); Sedentary PD rats (SEDþ PD); and exercised PD rats (EXþ PD). Statistical differences between groups for the same
brain hemisphere and between hemispheres for same group are presented as *p< 0.05; **p< 0.01; ***p< 0.001; ****p< 0.0001.
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optical density staining ratio between the aﬀected and
contralateral striatum correlated well with the
[18F]FDOPA uptake ratio (r2¼ 0.62, p< 0.0001)
(Figure 7(c)) (Supplementary data – Figure S3,
Table 7).
Discussion
The present study showed that exercise is able to sup-
press neurotoxin-induced glial activation, reduce
degeneration of the dopaminergic system and normal-
ize memory and motor deﬁcits in a rat model of PD.
Exercise has been suggested as a potential intervention
in neurodegenerative diseases. However, its beneﬁcial
eﬀects were only determined indirectly by assessment
of clinical symptoms or postmortem tissue analysis.
In this study, we directly demonstrated the eﬀects of
exercise on glial activation and the dopaminergic
system in a noninvasive manner using PET. Imaging
results were conﬁrmed by postmortem immunohisto-
chemical analysis.
Previous studies demonstrated that injection of 6-
OHDA in striatum increases the expression of micro-
glial markers and decreases TH expression.42 Despite
the small sample size for immunohistochemistry on day
10, Iba-1 staining in this study conﬁrmed that unilateral
6-OHDA injection in striatum causes robust microglial
activation, not only in striatum, but also in SNc and
hippocampus of sedentary PD rats. At day 30, acti-
vated microglia were still present in SNc, but not in
striatum and hippocampus. [11C]PBR28 PET provided
similar results as Iba-1 staining for striatum and hippo-
campus, but could not detect glial activation in SNc.
This can be explained by the limited spatial resolution
of the PET camera, which precluded analysis of small
brain structures, like SNc, in rats. When the whole mid-
brain was analyzed instead, glial activation could not
be detected since the speciﬁc signal derived from SNc
was averaged out over a large volume (partial volume
eﬀect). 6-OHDA injection not only caused microglia
activation, but also increased astrocyte density in the
striatum of sedentary rats, but not in SNc or hippocam-
pus. Sustained exercise was hypothesized to have anti-
inﬂammatory properties that can counteract the eﬀect
of 6-OHDA. In this study, both Iba-1 staining and PET
imaging showed that intermittently forced exercise
could indeed suppress the activation of microglia in
striatum, SNc and hippocampus. In line with our obser-
vation, previous studies described that exercise reduces
the number of circulating pro-inﬂammatory monocytes
and increases the number of regulatory T cells. In add-
ition, levels of anti-inﬂammatory and neuroprotective
molecules are enhanced in peripheral blood after phys-
ical activity.7 However, the mechanism through which
exercise aﬀects the immune system is not fully under-
stood yet.
At day 30, microglia activation had spontaneously
resolved in striatum and hippocampus, but not in SNc.
Microglia activation in SNc seems to be associated with
persistent dopaminergic injury. This observation is in
line with other studies in animals and postmortem stu-
dies on brain tissue of PD patients.43 Attempts to elu-
cidate how activated microglia contribute to neuronal
loss in the SNc have generated conﬂicting results.43 In
EXþPD animals, this persisting microglia activation
appeared to have caused somewhat less degeneration
of the dopaminergic system in SNc. Exercise may
have changed the phenotype of microglia in SNc from
the pro-inﬂammatory M1 to the anti-inﬂammatory
M2-phenotype before resolving to the resting state.7
A shortcoming of our study is that neither PET imaging
nor Iba-1 staining provided information about the
phenotype of the activated microglia.
In contrast to its modulatory eﬀect on microglia
activation, exercise was not able to suppress the activa-
tion of astrocytes in the striatum 10 days after surgery
in our study. Others, however, did observe a modula-
tory eﬀect of exercise on 6-OHDA-induced astrocyte
activation, which seemed to be associated with
improved motor function.44 In that study, a higher
dose of 6-OHDA (10 vs. 3 mg) was injected into the
medial forebrain bundle, resulting in persistent astro-
cyte activation in sedentary animals up to day 32.
Moreover, a more intense running protocol was used,
which may have caused a greater eﬀect on astrocytes.
Despite contradictory evidence in the literature, our
data suggest that exercise mainly has a modulatory
eﬀect on microglia rather than on astrocytes. In our
study, astrocyte activation was only observed in dorso-
lateral striatum close to the injection site, both in con-
trol and PD animals. These data corroborate a previous
study that observed an astrocyte reaction close to the
needle track in rats injected with vehicle solution.45
These activated astrocytes might be mainly involved
in restoration of damage to aﬀected tissue by inducing
glial scar formation.46
Our data showed that unilateral 6-OHDA injection
had a detrimental eﬀect on the dopaminergic system
in sedentary animals, as demonstrated by both
[18F]FDOPA PET and TH staining. However, dopa-
minergic damage in striatum appears to induce a com-
pensatory response, since the reduction in TH staining
was larger at day 10 after 6-OHDA injection than at
day 30. In SNc, such a spontaneous recovery was not
observed. This is in line with studies that revealed that
surviving dopaminergic neurons increase the dopamine
production, trying to compensate neuronal loss.
Exercise can intensify this compensatory mechanisms.10
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Exercise resulted in a partial reduction of dopamin-
ergic damage in the striatum at day 10 and complete
recovery at day 30. Exercise has been linked to protec-
tion of the dopaminergic system by increasing the
release of neurotrophic factors that can have anti-
inﬂammatory properties.5,7,8,10 The exercise-induced
reduction in dopaminergic damage observed in our
study seems, therefore, to be connected to the modula-
tory eﬀect of exercise on glial activation in striatum,
which could in turn have resulted in prevention of
inﬂammation-induced neuronal damage. In SNc, how-
ever, exercise did not have any eﬀect on TH staining at
day 10 at all, but resulted in partial recovery of the
dopaminergic damage at day 30. This indicates that
there was a decrease in the TH expression at day 10,
but neurons were not dead yet.
[18F]FDOPA PET results were highly correlated
with postmortem TH staining and reduced striatal
tracer uptake was associated with motor symptoms.
Kyono et al.12 showed that tracer uptake correlated
negatively with the severity of dopaminergic dysfunc-
tion. In another study, poor motor performance was
directly linked to a decline in striatal [18F]FDOPA
uptake.47 Prolonged reaction and movement time
were related to lower [18F]FDOPA uptake in the caud-
ate nucleus, and abnormalities in hand ﬁne force con-
trol were related to striatal [18F]FDOPA uptake. These
ﬁndings provide evidence that regional loss of nigros-
triatal inputs to frontostriatal networks aﬀects speciﬁc
aspects of motor function.
A relatively mild model of PD was used in our study
to enable detection of the beneﬁcial eﬀects of exercise.
The mild severity of the model was conﬁrmed by the
observation that intra-striatal injection of the neuro-
toxin 6-OHDA only had an eﬀect on body weight in
the ﬁrst week after surgery, but did not cause any
impairment of motor activity in the open ﬁeld test or
cylinder test at day 28/29. Previous studies showed def-
icits in motor activity when 80% of the dopaminergic
cells had been killed, while 55% of neuronal death did
not change locomotion.48,49 Apparently, in our study,
dopaminergic loss at day 28/29 was insuﬃcient to evoke
an eﬀect on motor activity. On the other hand, at day 9
after 6-OHDA injection, the cylinder test detected sig-
niﬁcant asymmetry in forelimb use in sedentary rats.
This apparent discrepancy could be ascribed to more
severe loss of dopamine synthesis at this time point, as
TH staining in striatum was reduced by approximately
50% at day 10, whereas only a 20% reduction was
found at day 30. Another possible explanation for
improved asymmetry forelimb use for SEDþPD ani-
mals at day 29 may be a compensatory mechanism of
the contralateral hemisphere, since the lesion of our
model is unilateral.50 If a compensatory mechanism
was present, however, it did not result in increased
[18F]FDOPA uptake in the control hemisphere. In con-
trast, previous studies did reveal compensatory changes
in the control hemisphere. This apparent discrepancy
can be explained by the mild PD model used in our
study, with dopaminergic loss being only 30–50%.
Compensatory mechanisms in the contralateral hemi-
sphere were described in unilateral PD models with
dopaminergic loss of more than 60%.51–55
Interestingly, intermittently forced exercise reduced
the degree of dopaminergic loss (30%) at day 9 after
6-OHDA injection, resulting in normalization of fore-
limb use in the cylinder test. Apparently, there is a
threshold for the amount of dopaminergic damage
that is required to induce motor symptoms.
Improvement in motor function as a result of exercise
has been associated with increased plasticity and den-
dritic spines,56 which could have been induced by the
release of neurotrophic factors.5,7,8,10
Non-motor symptoms, including memory impair-
ment, usually already appear in early stages of PD
and are increasingly recognized as a major challenge
in the treatment. Our study showed that injection of
6-OHDA aﬀects both short-term and long-term
memory in sedentary animals. The role of the dopamin-
ergic system in the NOR test has been demonstrated in
pharmacological studies, in which D1 and D2/D3
antagonists were applied.57 6-OHDA-induced dopa-
minergic loss in caudate and substantia nigra leads to
dysfunction of the prefrontal cortex, an area involved
short-term memory.58 Previous studies have also linked
microglia activation to non-motor symptoms in neuro-
degenerative diseases.59 We observed activation of
microglia, not only in the dopaminergic system but
also in the hippocampus, a brain region associated
with memory function. Memory deﬁcits observed in
our study may therefore also be related to activation
of microglia in hippocampus at day 10. Exercise was
able to suppress microglia activation in hippocampus,
which could also have been responsible for the preven-
tion of the deleterious eﬀects of 6-OHDA on memory.
Moreover, exercise may have increased neuroplasticity
of corticostriatal circuits, resulting in modulation of
dopamine and glutamate neurotransmission, synapto-
genesis, and cerebral blood ﬂow.60 Thus, exercise may
be able to improve cognitive function in PD by either
preventing dopaminergic loss or suppressing glial
activation.
Conclusions
The present study corroborates previous ﬁndings sug-
gesting intermittent exercise could have the potential to
become an (add-on) non-pharmacological intervention
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for PD. Exercise has a modulating eﬀect on activation
of microglia after exposure to 6-hydroxydopamine.
Exercise-induced attenuation of microglia seems to
have a beneﬁcial eﬀect on preservation and/or recovery
of the dopaminergic system, cognition and motor func-
tion. The present study also demonstrated that PET
enables noninvasive, longitudinal monitoring of the
modulating eﬀects of exercise on glial activation and
degeneration of presynaptic dopaminergic neurons.
The modulating eﬀect of exercise, the 6-OHDA-
induced glial activation measured by [11C]PBR28 PET
was conﬁrmed by Iba-1 staining, whereas [18F]FDOPA
PET correlated well with TH staining and behavioral
symptoms. These results warrant elaborate longitudinal
studies assessing the beneﬁcial eﬀects of exercise on PD
progression using PET.
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